Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rieke Baumkötter"'
Autor:
Rieke Baumkötter, Simge Yilmaz, Daniela Zahn, Katharina Fenzl, Jürgen H. Prochaska, Heidi Rossmann, Irene Schmidtmann, Alexander K. Schuster, Manfred E. Beutel, Karl J. Lackner, Thomas Münzel, Philipp S. Wild
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background During the SARS-CoV-2 pandemic, preventive measures like physical distancing, wearing face masks, and hand hygiene have been widely applied to mitigate viral transmission. Beyond increasing vaccination coverage, preventive measure
Externí odkaz:
https://doaj.org/article/9d007b025a1a4339ad4e16b357f46fbb
Autor:
Markus Schepers, Irene Schmidtmann, Daniela Zahn, Philipp Wild, Manfred Beutel, Alexander K Schuster, Thomas Münzel, Karl J Lackner, Katharina Geschke, Jörn Schattenberg, Rieke Baumkötter, Simge Yilmaz, Daniel Wollschläger
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0280292 (2023)
Previous evidence suggested that non-COVID-19-related medical care was reduced during the first wave of the COVID-19 pandemic, but it remained unclear whether or to which extent this effect lasted beyond the first wave, or existed in a longer time fr
Externí odkaz:
https://doaj.org/article/f522a8d4acf749a48e2f4bd7d91b2d13
Autor:
Julia Petersen, Nora Hettich, Rieke Baumkötter, Philipp S. Wild, Norbert Pfeiffer, Thomas Münzel, Jochem König, Karl J. Lackner, Manfred E. Beutel
Publikováno v:
Frontiers in Sociology, Vol 7 (2022)
BackgroundIndividuals living at-risk-of-poverty have an increased risk of poor mental health. The pandemic and its societal impacts might have negative effects especially on this group widening the gap between rich and poor and also exacerbate gender
Externí odkaz:
https://doaj.org/article/65c38e332e864775b0bcf7a74ace87af
Autor:
Jürgen H. Prochaska, Claus Jünger, Andreas Schulz, Natalie Arnold, Felix Müller, Marc William Heidorn, Rieke Baumkötter, Daniela Zahn, Thomas Koeck, Sven-Oliver Tröbs, Karl J. Lackner, Andreas Daiber, Harald Binder, Sanjiv J. Shah, Tommaso Gori, Thomas Münzel, Philipp S. Wild
Publikováno v:
Clinical Research in Cardiology.
Background The sodium-glucose co-transporter 2 inhibitor empagliflozin improves cardiovascular outcome in patients with type 2 diabetes mellitus (T2DM) and heart failure. Experimental studies suggest a direct cardiac effect of empagliflozin associate